643 related articles for article (PubMed ID: 28253211)
21. Prognostic Value of Non-Invasive Fibrosis and Steatosis Tools, Hepatic Venous Pressure Gradient (HVPG) and Histology in Nonalcoholic Steatohepatitis.
Sebastiani G; Alshaalan R; Wong P; Rubino M; Salman A; Metrakos P; Deschenes M; Ghali P
PLoS One; 2015; 10(6):e0128774. PubMed ID: 26083565
[TBL] [Abstract][Full Text] [Related]
22. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
[TBL] [Abstract][Full Text] [Related]
23. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver Transplantation.
Miyaaki H; Miuma S; Taura N; Shibata H; Sasaki R; Soyama A; Hidaka M; Takatsuki M; Eguchi S; Nakao K
Transplantation; 2019 Jan; 103(1):109-112. PubMed ID: 29894414
[TBL] [Abstract][Full Text] [Related]
25. Most Cases of Cryptogenic Cirrhosis May Be Nonobese Nonalcoholic Steatohepatitis - Risk Factors of Liver Steatosis After Liver Transplantation for Cryptogenic Cirrhosis: A Retrospective Study.
Fukushima M; Miyaaki H; Sasaki R; Haraguchi M; Miuma S; Hara T; Soyama A; Hidaka M; Eguchi S; Nakao K
Intern Med; 2023 May; 62(10):1415-1423. PubMed ID: 36171128
[TBL] [Abstract][Full Text] [Related]
26. Natural history of NASH cirrhosis in liver transplant waitlist registrants.
Lim WH; Ng CH; Tan D; Tseng M; Xiao J; Yong JN; Zeng RW; Cho E; Tay P; Ang CZ; Koh JH; Teng M; Syn N; Kow A; Huang DQ; Tan EX; Rinella ME; Sanyal A; Muthiah M; Siddiqui MS
J Hepatol; 2023 Oct; 79(4):1015-1024. PubMed ID: 37307997
[TBL] [Abstract][Full Text] [Related]
27. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
Wong RJ; Ahmed A
Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
[TBL] [Abstract][Full Text] [Related]
28. Perspectives on Treatment for Nonalcoholic Steatohepatitis.
Lassailly G; Caiazzo R; Pattou F; Mathurin P
Gastroenterology; 2016 Jun; 150(8):1835-48. PubMed ID: 26971824
[TBL] [Abstract][Full Text] [Related]
29. Liver transplantation for nonalcoholic steatohepatitis in young patients.
Alkhouri N; Hanouneh IA; Zein NN; Lopez R; Kelly D; Eghtesad B; Fung JJ
Transpl Int; 2016 Apr; 29(4):418-24. PubMed ID: 26402655
[TBL] [Abstract][Full Text] [Related]
30. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
31. Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years.
Kawanaka M; Nishino K; Morimoto Y; Ishii K; Tanikawa T; Urata N; Suehiro M; Sasai T; Haruma K; Kawamoto H
Intern Med; 2021 May; 60(9):1397-1401. PubMed ID: 33281161
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and risk factors of steatosis after liver transplantation and patient outcomes.
Hejlova I; Honsova E; Sticova E; Lanska V; Hucl T; Spicak J; Jirsa M; Trunecka P
Liver Transpl; 2016 May; 22(5):644-55. PubMed ID: 26707008
[TBL] [Abstract][Full Text] [Related]
33. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
[TBL] [Abstract][Full Text] [Related]
34. Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver Disease.
Bhanji RA; Narayanan P; Moynagh MR; Takahashi N; Angirekula M; Kennedy CC; Mara KC; Dierkhising RA; Watt KD
Liver Transpl; 2019 Jan; 25(1):14-24. PubMed ID: 30257063
[TBL] [Abstract][Full Text] [Related]
35. Liver Transplantation for Alcoholic and Nonalcoholic Fatty Liver Disease: Pretransplant Selection and Posttransplant Management.
Siddiqui MS; Charlton M
Gastroenterology; 2016 Jun; 150(8):1849-62. PubMed ID: 26971826
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Holzner ML; Florman S; Schwartz ME; Tabrizian P
HPB (Oxford); 2022 Apr; 24(4):470-477. PubMed ID: 34544629
[TBL] [Abstract][Full Text] [Related]
37. Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence.
Ghabril M; Dickson RC; Krishna M; Machicao V; Aranda-Michel J; Bonatti H; Nguyen JH
Liver Transpl; 2011 Jun; 17(6):685-94. PubMed ID: 21618689
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
[TBL] [Abstract][Full Text] [Related]
39. Acidophil bodies in nonalcoholic steatohepatitis.
Yeh MM; Belt P; Brunt EM; Kowdley KV; Wilson LA; Ferrell L;
Hum Pathol; 2016 Jun; 52():28-37. PubMed ID: 26980020
[TBL] [Abstract][Full Text] [Related]
40. Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsies.
Lin TY; Yeh ML; Huang CF; Huang CI; Dai CY; Hsieh MH; Chen SC; Huang JF; Yu ML; Chuang WL
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):224-229. PubMed ID: 30308578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
